Zobrazeno 1 - 10
of 22
pro vyhledávání: '"A G, Richetta"'
Autor:
D. Orsini, M. Megna, C. Assorgi, A. Balato, R. Balestri, N. Bernardini, A. Bettacchi, T. Bianchelli, L. Bianchi, G. Buggiani, M. Burlando, AMG. Brunasso, G. Caldarola, N. Cameli, A. Campanati, E. Campione, A. Carugno, K. Chersi, A. Conti, A. Costanzo, E. Cozzani, A. Cuccia, D. D’Amico, G. Dal Bello, E. G. Dall’Olio, P. Dapavo, C. De Simone, E. V. Di Brizzi, A. Di Cesare, V. Dini, M. Esposito, E. Errichetti, M. C. Fargnoli, C. S. Fiorella, A. Foti, Z. Fratton, F. M. Gaiani, P. Gisondi, R. Giuffrida, A. Giunta, C. Guarneri, A. Legori, F. Loconsole, P. Malagoli, A. Narcisi, M. Paolinelli, L. Potestio, F. Prignano, G. Rech, A. Rossi, N. Skroza, F. Trovato, M. Venturini, A. G. Richetta, G. Pellacani, A. Dattola
Publikováno v:
Journal of Dermatological Treatment, Vol 35, Iss 1 (2024)
Purpose of the article: The aim of this multicenter observational study is to report data from real world on the use of bimekizumab in patients aged ≥ 65 years with moderate-to-severe plaque psoriasis. Elderly patients are poorly represented in cli
Externí odkaz:
https://doaj.org/article/7ef04e4cae9b4655894c0414dffd2eb3
Autor:
Diego Orsini, Giacomo Caldarola, Annunziata Dattola, Elena Campione, Nicoletta Bernardini, Pasquale Frascione, Clara De Simone, Antonio G. Richetta, Marco Galluzzo, Nevena Skroza, Chiara Assorgi, Emanuele Amore, Gennaro M. Falco, Ruslana Gaeta Shumak, Fabio Artosi, Giulia Maretti, Concetta Potenza, Luca Bianchi, Giovanni Pellacani, Ketty Peris, Claudio Bonifati, Dario Graceffa
Publikováno v:
Journal of Dermatological Treatment, Vol 35, Iss 1 (2024)
Purpose of the article: Interleukin-23 inhibitors, such as tildrakizumab, have emerged as safe and effective options for the management of psoriasis. Yet their efficacy in elderly patients (aged 65 years or more), particularly in those with difficult
Externí odkaz:
https://doaj.org/article/6ed0bed7541c4a9084145e7ddf8bf2a1
Autor:
Diego Orsini, Piergiorgio Malagoli, Anna Balato, Luca Bianchi, Pina Brianti, Dario Buononato, Martina Burlando, Giacomo Caldarola, Anna Campanati, Elena Campione, Carlo G. Carrera, Andrea Carugno, Francesco Cusano, Paolo Dapavo, Annunziata Dattola, Clara De Simone, Valentina Dini, Maria Esposito, Maria C. Fargnoli, Francesca M. Gaiani, Luigi Gargiulo, Paolo Gisondi, Alessandro Giunta, Luciano Ibba, Claudia Lasagni, Francesco Loconsole, Vincenzo Maione, Edoardo Mortato, Angelo V. Marzano, Martina Maurelli, Matteo Megna, Santo R. Mercuri, Alessandra Narcisi, Annamaria Offidani, Giovanni Paolino, Aurora Parodi, Giovanni Pellacani, Luca Potestio, Pietro Quaglino, Antonio G. Richetta, Francesca Romano, Paolo Sena, Marina Venturini, Chiara Assorgi, Antonio Costanzo
Publikováno v:
Dermatology Practical & Conceptual, Vol 14, Iss 2 (2024)
Introduction: Genital involvement is observed in approximately 60% of patients with psoriasis, presenting clinicians with formidable challenges in treatment. While new biologic drugs have emerged as safe and effective options for managing psoriasis,
Externí odkaz:
https://doaj.org/article/59fd209fd8eb441cabd179657001da3a
Autor:
Luigi Gargiulo, Alessandra Narcisi, Luciano Ibba, Anna Balato, Luca Bianchi, Pina Brianti, Dario Buononato, Martina Burlando, Giacomo Caldarola, Anna Campanati, Elena Campione, Carlo G. Carrera, Andrea Carugno, Antonio Cristaudo, Francesco Cusano, Paolo Dapavo, Annunziata Dattola, Clara De Simone, Francesca M. Gaiani, Paolo Gisondi, Alessandro Giunta, Francesco Loconsole, Vincenzo Maione, Edoardo Mortato, Angelo V. Marzano, Martina Maurelli, Matteo Megna, Santo R. Mercuri, Annamaria Offidani, Diego Orsini, Aurora Parodi, Giovanni Pellacani, Luca Potestio, Pietro Quaglino, Antonio G. Richetta, Francesca Romano, Paolo Sena, Marina Venturini, Piergiorgio Malagoli, Antonio Costanzo
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
IntroductionBimekizumab is a monoclonal antibody that targets Interleukin-17 A and F, approved for the treatment of moderate-to-severe plaque psoriasis. While bimekizumab has been evaluated in several phase-III clinical trials, real-world evidence is
Externí odkaz:
https://doaj.org/article/a57a586330ad40f1847d355dbee4ceef
Autor:
Ugo BOTTONI, Rita CLERICO, Antonio G. RICHETTA, Vincenzo PANASITI, Paola CORSETTI, Vincenzo ROBERTI, Giovanni PAOLINO, Elisa MOLITERNI, Sara GRASSI, Stefano CALVIERI
Publikováno v:
Italian Journal of Dermatology and Venereology. 158
Autor:
Federica MARRAFFA, Agneszka DYBALA, Sara GRASSI, Federica REGA, Vincenzo ROBERTI, Andrea VIZZACCARO, Simone MICHELINI, Giovanni PELLACANI, Antonio G. RICHETTA
Publikováno v:
Italian journal of dermatology and venereology. 157(5)
Multimethod and Interpersonal Assessment in Medical Settings: A Case Study from the Dermatology Unit
Autor:
Chiara Vari, Patrizia Velotti, Giulio Cesare Zavattini, Antonio G. Richetta, Stefano Calvieri
Publikováno v:
Mediterranean Journal of Clinical Psychology, Vol 1, Iss 3 (2014)
Psoriasis is a chronic skin disease with multifactorial aetiology. The psychological impact of skin diseases is increasingly recognised, but only scant attention has been given to the possible role of couple relationships as protective factors for de
Externí odkaz:
https://doaj.org/article/7870f3f2c6194bc2a4366d3a2562178b
Publikováno v:
Dermatology Research and Practice, Vol 2009 (2009)
Pyoderma gangrenosum (PG) is a neutrophilic dermatosis of unknown aetiology. Clinical manifestations of PG are characterized by destructive, necrotizing, and noninfective ulceration of the skin. 20–30% of cases are initiated and aggravated by minor
Externí odkaz:
https://doaj.org/article/8c3b0b10c17e4228965f99fb7136cc25
Autor:
S, D'Epiro, M, Salvi, A, Luzi, C, Mattozzi, C, Luci, L, Macaluso, F, Marzocca, V, Salvo, C, Cantisani, G, Paolino, S, Calvieri, A G, Richetta
Publikováno v:
La Clinica terapeutica. 165(4)
Skin ulcers are defined as tissue loss interesting the deeper layers of the dermis and hypodermis, with low tendency to spontaneous healing. They cause disability related to pain, risk of infection and amputation, chronic management, requiring workin
Publikováno v:
Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia. 149(1)
Biologics were introduced as innovative and effective therapies for the treatment of moderate-to severe psoriasis. However, in the Italian context there are no comparative cost-effectiveness analyses of all biologics currently approved for psoriasis